Galmed Pharmaceuticals GLMD
NASDAQ GLMD
$4.56 -0.21 (-4.46%)
At close: Aug 20, 2026 · 4:00 PM EDT

Galmed Pharmaceuticals (GLMD) EBT Margin (2016 - 2018)

Galmed Pharmaceuticals (GLMD) posted quarterly EBT Margin of 58.93% for Q3 2018, down 96707.0% year-over-year from N/an in Q3 2017, and up 2373.14% quarter-over-quarter from 2.59% in Q2 2018.

Galmed Pharmaceuticals (GLMD) EBT Margin (2016 - 2018) Analysis & Trends

Galmed Pharmaceuticals' EBT Margin history runs 3 years deep, the most recent figure standing at 58.93% for Q3 2018.

  • In Q3 2018, EBT Margin fell 96707.0% year-over-year to 58.93%; the TTM figure through Jun 2019 stood at 256.38% (down 33965.0% YoY), while the FY2018 annual figure was 479.93%, down 65362.0% from the prior year.
  • EBT Margin for Q3 2018 stood at 58.93%, up from 2.59% in the prior quarter.
  • The five-year high for EBT Margin was 1931.09% in Q3 2016, with the low at 2.59% in Q2 2018.
  • The 3-year median for EBT Margin is 1026.01% (2017), against an average of 921.96%.
  • The sharpest annual moves came in 2017 and 2018: EBT Margin plunged 43139 bps in 2017, then plunged 117425 bps in 2018.
  • Galmed Pharmaceuticals' EBT Margin stood at 1761.31% in 2016, then slipped by 24 bps to 1329.93% in 2017, then plunged by 96 bps to 58.93% in 2018.
  • Business Quant data shows GLMD's EBT Margin at 58.93% in Q3 2018, 2.59% in Q2 2018, and 10.82% in Q1 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 35.61%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 35.71%
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -528.97%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 18.33%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 13.77%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -2.67%
8 Royalty Pharma 26.98 Bn 26.14 Bn - 12.09%
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -25.06%
10 Galmed Pharmaceuticals 2.39 Mn -9.49 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2018 58.93%
Jun 30, 2018 -2.59%
Mar 31, 2018 10.82%
Dec 31, 2017 1,329.93%
Sep 30, 2017 1,026.01%
Jun 30, 2017 997.04%
Mar 31, 2017 1,185.07%
Dec 31, 2016 1,761.31%
Sep 30, 2016 1,931.09%